France· FR:66854318
PRIMALAN 10 mg, comprimé sécable
A mequitazine product containing méquitazine, registered in France by PIERRE FABRE MEDICAMENT, on the national reimbursement list. The same ATC class is registered in 2 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Mequitazine is registered in 2 of 19 countries.
Countries holding a registration under ATC R06AD07 (mequitazine), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 1 of them publish a price we can compare per daily dose
Mequitazine · ATC R06AD07
2 / 19 countries
- Franceprice
- Japan
Price per daily dose
What a daily dose of mequitazine costs, country by country.
Normalised to the WHO defined daily dose (10 mg), so markets compare like for like.
- France: $0.29 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Mequitazine · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- FR France$0.29
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- MÉQUITAZINE
- Manufacturer
- PIERRE FABRE MEDICAMENT
- Country
- France (FR)
- ATC code
- R06AD07
- ATC class
- Mequitazine
- Defined daily dose
- 10 mg, O
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400933958329plaquette(s) PVC-Aluminium de 14 comprimé(s)EUR 3.06
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under R06AD07
Mequitazine, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e089a527-68a5-4441-9f5b-677b0b77cd46 GET /v1/drugs/e089a527-68a5-4441-9f5b-677b0b77cd46?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "66854318",
"date_amm": "1995-10-02",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "MÉQUITAZINE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé sécable",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about mequitazine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.